Overview
Lobbying Costs
250,000€
Financial year: Jan 2020 - Dec 2020
Lobbyists (Full time equivalent)
5.75 Fte (8)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
ABIEL S.r.l. (ABIEL)
EU Transparency Register
141837410320-27 First registered on 14 Dec 2012
Goals / Remit
Our mission is to develop, produce, and commercialize new molecules and substances active in the extracellular matrix's lysis. We are especially interested in new enzymes that are capable of optimizing tissue digestion procedures with particular regard to the field of regenerative medicine. Besides, we aim to become a leader in the research and industrial production of lytic enzymes through the constant applied research and the worldwide sales of our innovative products. In the last period, we have upgraded our interest in the extracellular matrix component of marine origin usable in regenerative medicine. Such as in the preindustrial synthesis of the luminescent molecule.
Main EU files targeted
We would like to be informed on Guidelines on Good Manufacturing Practice (GMP) specific for Advanced Therapy Medicinal Products (ATMP)
Address
Head Office
Viale delle Scienze, 16
c/o Consorzio ARCA
Palermo 90128
ITALY -
People
Total lobbyists declared
8
Employment time Lobbyists 100% 5 25% 3 Lobbyists (Full time equivalent)
5.75
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Aderiamo ad Assobiotec Italia
Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2020 - Dec 2020
Lobbying costs for closed financial year
250,000€
EU grant income for closed financial year
174,000 € (Source: H2020)
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
We partecipate to Europea Community projects:
- DRIVE project number 645991;
- FutForm project number 691128;
- ARTIBLED project number 863170.
- K.C. Scheiner, F. Coulter, R.F. Maas-Bakker, G. Ghersi, T.T. Nguyen, R Steendam, G.P. Duffy, W E. Hennink, E.D. O’Cearbhaill, R.J. Kok "Vascular Endothelial Growth FactoreReleasing Microspheres
Based on Poly(ε-Caprolactone-PEG-ε-Caprolactone)-b-Poly(L-Lactide) Multiblock Copolymers Incorporated in a Three-Dimensional Printed poly (Dimethyl-siloxane) Cell Macroencapsulation Device". Journal of Pharmaceutical Sciences 109 (2020) 863-870.
- Salamone M, Nicosia A, Ghersi G, Tagliavia M. Vibrio Proteases for Biomedical Applications: Modulating the Proteolytic Secretome of V. alginolyticus and V. parahaemolyticus for Improved Enzymes Production. Microorganisms. 2019 Sep 24;7(10). pii: E387. doi: 10.3390/microorganisms7100387.
- Sabatino MA, Carfì Pavia F, Rigogliuso S, Giacomazza D, Ghersi G, La Carrubba V, Dispenza C. Development of injectable and durable kefiran hydro-alcoholic gels. Int J Biol Macromol. 2020 Jan 25;149:309-319. doi: 10.1016/j.ijbiomac.2020.01.244.
- Rigogliuso, S., Salamone, M., Barbarino, E., Barbarino, M., Nicosia, A. and Ghersi, G. “Production of Injectable Marine Collagen-Based Hydrogel for the Maintenance of Differentiated Chondrocytes in Tissue Engineering Applications” 2020 International journal of molecular sciences, Volume 21, Issue 16 doi:10.3390/ijms21165798Other activities
nessuna
Meetings
Meetings
None declared